Quick Answer
ADC Therapeutics SA reported Total Assets of $323.15 million for fiscal year 2025.
ADC Therapeutics SA Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $323.15M | +0.4% |
| 2024 | $321.98M | -9.2% |
| 2023 | $354.78M | -27.7% |
| 2022 | $490.86M | -20.6% |
| 2021 | $617.97M | +20.3% |
| 2020 | $513.69M | +273.1% |
| 2019 | $137.68M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $289.76M | -17.0% | -9.9% |
| June 30, 2025 | $321.56M | -13.5% | +18.0% |
| March 31, 2025 | $272.54M | -11.5% | -15.4% |
| December 31, 2024 | $321.98M | -9.2% | -7.8% |
| September 30, 2024 | $349.08M | — | -6.1% |
| June 30, 2024 | $371.78M | — | +20.7% |
| March 31, 2024 | $307.97M | — | -13.2% |
| December 31, 2023 | $354.78M | — | — |
- ADC Therapeutics SA showed an increase of +0.4% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, ADC Therapeutics SA’s total assets has grown by 134.7% (from $137.68 million to $323.15 million).
- The most recent figure is from ADC Therapeutics SA’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: